Changes in Transmucosal Buprenorphine Utilization for Opioid Use Disorder Treatment During the COVID-19 Pandemic in Kentucky
Link
Description
Explores changes in prescription rates of transmuscosal buprenorphine for the treatment of opioid use disorder during the COVID-19 pandemic in Kentucky. Compares prescribing rates in rural versus urban areas and examines rates on a week by week basis.
Author(s)
Feitong Lei, Michelle R. Lofwall, Patricia R. Freeman, et al.
Citation
Journal of Rural Health, 39(1), 186-196
Date
12/2022
Tagged as
Access
· COVID-19
· Illicit drug use
· Pharmacy and prescription drugs
· Prescription drug misuse
· Rural-urban differences
· Statistics and data
· Wellness, health promotion, and disease prevention
· Kentucky